Chemically induced mouse models of acute and chronic intestinal inflammation
- PMID: 28569761
- DOI: 10.1038/nprot.2017.044
Chemically induced mouse models of acute and chronic intestinal inflammation
Abstract
Inflammatory bowel diseases (IBDs) result in diarrhea and abdominal pain with further potential complications such as tissue fibrosis and stenosis. Animal models help in understanding the immunopathogenesis of IBDs and in the design of novel therapeutic concepts. Here we present an updated version of a protocol we published in 2007 for key models of acute and chronic forms of colitis induced by 2,4,6-trinitro-benzene sulfonic acid (TNBS), oxazolone and dextran sulfate sodium (DSS). This protocol update describes an adaptation of the existing protocol that modifies the technique. This protocol has been used to generate improved mouse models that better reflect the nature of IBDs in humans. In TNBS and oxazolone colitis models, topical administration of hapten reagents results in T-cell-mediated immunity against haptenized proteins and luminal antigens. By contrast, to generate DSS colitis models, mice orally receive DSS, causing death of epithelial cells, compromising barrier function and causing subsequent inflammation. The analysis of the acute colitis models can be performed within 1-2 weeks, whereas that of the chronic models may take 2-4 months. The strengths of the acute models are that they are based on the analysis of short-lasting barrier alterations, innate immune effects and flares. The advantages of the chronic models are that they may offer better insight into adaptive immunity and complications such as neoplasia and tissue fibrosis. The protocol requires basic skills in laboratory animal research.
Similar articles
-
Chemically induced mouse models of intestinal inflammation.Nat Protoc. 2007;2(3):541-6. doi: 10.1038/nprot.2007.41. Nat Protoc. 2007. PMID: 17406617
-
Chemically induced mouse models of colitis.Curr Protoc Pharmacol. 2009 Sep;Chapter 5:Unit 5.55. doi: 10.1002/0471141755.ph0555s46. Curr Protoc Pharmacol. 2009. PMID: 22294401
-
Comparison of experimental mouse models of inflammatory bowel disease.Int J Mol Med. 2014 Feb;33(2):333-40. doi: 10.3892/ijmm.2013.1569. Epub 2013 Nov 27. Int J Mol Med. 2014. PMID: 24285285
-
Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.World J Gastroenterol. 2007 Nov 14;13(42):5581-93. doi: 10.3748/wjg.v13.i42.5581. World J Gastroenterol. 2007. PMID: 17948932 Free PMC article. Review.
-
Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease.Int J Mol Sci. 2022 Aug 19;23(16):9344. doi: 10.3390/ijms23169344. Int J Mol Sci. 2022. PMID: 36012618 Free PMC article. Review.
Cited by
-
Mouse Models of Intestinal Fibrosis.Methods Mol Biol. 2021;2299:385-403. doi: 10.1007/978-1-0716-1382-5_26. Methods Mol Biol. 2021. PMID: 34028756 Free PMC article.
-
TRPV4 is expressed by enteric glia and muscularis macrophages of the colon but does not play a prominent role in colonic motility.bioRxiv [Preprint]. 2024 Jan 11:2024.01.09.574831. doi: 10.1101/2024.01.09.574831. bioRxiv. 2024. PMID: 38260314 Free PMC article. Preprint.
-
Food colorants metabolized by commensal bacteria promote colitis in mice with dysregulated expression of interleukin-23.Cell Metab. 2021 Jul 6;33(7):1358-1371.e5. doi: 10.1016/j.cmet.2021.04.015. Epub 2021 May 13. Cell Metab. 2021. PMID: 33989521 Free PMC article.
-
Trypsin inhibitor LH011 inhibited DSS-induced mice colitis via alleviating inflammation and oxidative stress.Front Pharmacol. 2022 Sep 27;13:986510. doi: 10.3389/fphar.2022.986510. eCollection 2022. Front Pharmacol. 2022. PMID: 36238566 Free PMC article.
-
Upregulation of TCPTP in Macrophages Is Involved in IL-35 Mediated Attenuation of Experimental Colitis.Mediators Inflamm. 2024 Jun 13;2024:3282679. doi: 10.1155/2024/3282679. eCollection 2024. Mediators Inflamm. 2024. PMID: 38962170 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources